Ostivea

Ostivea Overdosage

ibandronic acid

Manufacturer:

UNAM Pharmaceutical

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
No specific information is available on the treatment of overdosage with ibandronic acid.
Based on knowledge of this class of compounds, intravenous overdosage may result in hypocalcaemia, hypophosphataemia, and hypomagnesaemia. Clinically relevant reductions in serum levels of calcium, phosphorus, and magnesium should be corrected by intravenous administration of calcium gluconate, potassium or sodium phosphate, and magnesium sulfate, respectively.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in